It is only a shit show because of the poor management and lack of forward thought by company management, a chance to get a foot into the US market, even at 5% profit as you put it is better than nothing especially since it has been acknowledged that long term FDA approval is on the table, for approved companies.
If A2m don't want IF into the US why are they running a loss making milk business there.
Lets just throw another loss making venture into the realm. MVM is expected to loose around 10+mill a year for the next few years, not to mention the write offs already taken into account, plus no chance of profit before 2025. Under your view of good company management this most certainly is a shit show.
MVM is a loss making venture for the long term outlook of the company, the US has a chance to at least break even and gain a chance of grabbing a foot in the long term in a fairly large market, what makes better business sense, I guess lets just concentrate on one large customer market, China, so that just maybe we can have a repeat of what has occurred in the last couple of years, there is logic there somewhere.
A2M Price at posting:
$4.88 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)